TRAVERE THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Due in Rolling after Year Five
TRAVERE THERAPEUTICS, INC. (TVTX) had Operating Leases, Future Minimum Payments, Due in Rolling after Year Five of $4.22 million as of 2017-12-31, per its 10-K filed 2018-07-06.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive · last filed 2018-07-06
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Rolling after Year Five $4.22M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Rolling after Year Five $4.86M.
- 2017-06-30: Operating Leases, Future Minimum Payments, Due in Rolling after Year Five $806.00K.
- 2017-03-31: Operating Leases, Future Minimum Payments, Due in Rolling after Year Five $2.15M.
| Period end | Operating Leases, Future Minimum Payments, Due in Rolling after Year Five | Operating Leases, Future Minimum Payments, Due in Rolling after Year Five as first filed |
|---|---|---|
| 2017-12-31 | $4.22M 10-K · filed 2018-07-06 | |
| 2017-09-30 | $4.86M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $806.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $2.15M 10-Q · filed 2017-05-05 | |
| 2016-09-30 | $5.02M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $3.45M 10-K · filed 2017-03-01 | $0.00 10-K · filed 2016-02-26 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |